Claris Bio

Drug Discovery · Jersey City, NJ · Founded 2018 · Privately Held (backing)

Developer of a topical formulation technology designed to treat orphan ophthalmic disorders. Claris Bio is based in Jersey City, NJ and was founded in 2018. It was valued at $163 million at its later-stage round in Nov 2025, the last priced event on record. It has raised $154 million across 1 recorded round; the latest was a $54.5 million Series A in Jan 2024.

PMV mark · valuation
$163.4M
Oct 2026
Priced at
its later-stage round
Nov 2025
Total raised
$153.6M
Last round
Later Stage VC (Series A)
Jan 2024
How much has Claris Bio raised?
$153.6Macross 1 recorded rounds · Jan 2024 – Jan 2024

Most recently, Claris Bio raised $54.5M in its Later Stage VC (Series A) (Jan 2024).

Free account
More of Claris Bio with a free account
  • ·Watch Claris Bio: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Claris Bio round by round

1 rounds
Jan 2024Later Stage VC (Series A)$54.5M▮
+ 1 more investors · free account

How much has Claris Bio raised?

Claris Bio has raised $154 million in total; 1 of its rounds is on record. The largest on record was a $54.5 million Series A in Jan 2024.

Claris Bio investors

5 investors are on record for Claris Bio, including RA Capital Management, Novo Holdings, Catalio Capital Management and Janus Henderson Investors. The Series A in Jan 2024 drew 3 investors.

For fundraisers
Raising for a company like Claris Bio?

5 investors have backed Claris Bio — start your target list with the firms already writing checks in drug discovery.

See all 5 investors →

Frequently asked about Claris Bio

How much has Claris Bio raised?
Claris Bio has raised $153.6M in total across 1 recorded funding rounds.
When was Claris Bio's last funding round?
Claris Bio's most recent recorded round was Later Stage VC (Series A) in Jan 2024, raising $54.5M.